CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancer. Niu X, Wang W, Liang T, Li S, et al. Cancer Sci 2022;113:28-40.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Niu X, Wang W, Liang T, Li S, et al. CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancer. Cancer Sci 2022;113:28-40.
PMID: 34727389